Account-based marketing (ABM) and Account-based experiences (ABX) have become the cornerstones of B2B revenue growth — but implementing this approach in cell and gene therapy organizations can be challenging.
With growing competition, longer sales cycles and more decision makers involved, is it the most effective way to build trust?
Join your peers in this virtual roundtable as we share our insights into what’s needed to make ABM a success for CGT tools and tech.
📍Identifying prospects: Using data to find prospects with the potential for growth, long-term value, and strategic fit.
📍Multi-channel vs omni-channel: Touchpoints to reach prospects with the right message at the right time.
📍Organizational alignment: Get sales, marketing, R&D and scientific teams on the same page with the strategy.
This core segment of the virtual roundtable delves into the predetermined topic, facilitated by the moderator. Participants are encouraged to share insights, experiences, and perspectives, fostering a rich, collaborative dialogue. This hour-long discussion aims to share common challenges, explore solutions, trends, and innovative ideas.
2410 virtual roundtables are an exclusive forum that bring together life science executives to engage in candid discussion, share insight and collaborate on common challenges facing cell therapy developers today.
Facilitated by Michael Adeniya, a professional host with 15+ years in advanced therapies, you'll be an active participant in the discussion.
You'll leave with practical strategies to implement in your organization.
Enhance your approach and drive growth with insights gained from the roundtable. All gained from the comfort of your own office!
